Tiny OncoSec Surges on Promising Phase II Melanoma Data Post author:Sam Post published:November 7, 2017 Post category:BioPharma The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace You Might Also Like <b>Revon Systems</b> Working With To Build Next Generation Clinical Algorithms September 6, 2017 Valeant to Shave an Additional $200M From Its Mountain of Debt January 25, 2018 Merck Plots 950-Job R&D Hub in London November 26, 2017